Daily oral PrEP is highly effective, but taking a pill consistently can be challenging. Could long-acting injectable cabotegravir help close gaps in HIV prevention? What would it take to make it available through Brazil’s public health system? In this episode, the authors discuss the ImPrEP CAB Brasil study, which evaluated same-day access to injectable PrEP across six Brazilian cities, explore what the study found about PrEP coverage, participant choice, and delivering CAB-LA in routine care, as well as the questions that remain for equitable access and scale-up.

Click here to read the full article:

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00201-8/fulltext

Ebola outbreaks occur in areas where many people are living with HIV; however, there is very little evidence on how people with HIV respond to Ebola vaccines. In this edition of the podcast, we talk to authors of a study assessing the safety and immunogenicity of an Ebola vaccine in people with well controlled HIV.

Click here to read the full article:

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00118-9/fulltext

HIV remains underdiagnosed among men in many settings, contributing to ongoing transmission. When women seek care during pregnancy, there is an opportunity to reach out to their partners. Home-based couples testing and counselling can help to identify HIV and discuss other health issues. In this podcast, we look at a trial comparing lay counsellor delivered couples-based HIV testing with distributions of self-test kits, and standard of care in Kenya.

Click here to read the full article:

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00104-9/fulltext